Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Browse the detailed record of transactions filed by Schwalm Cynthia, Director. Insider active across 1 company, notably G1 Therapeutics, Inc.. Aggregated, 1 filings have been published. History available since 17 June 2021. The latest transaction was disclosed on 17 June 2021 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration
Cynthia Schwalm is a Board Member at G1 Therapeutics, Inc. She plays a key role in the governance of the company, providing strategic advice and overseeing growth initiatives. Her expertise in the biopharmaceutical sector is valuable for the company's future direction.